Financial Snapshot

This section of the Fusion Pharmaceuticals InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Fusion Pharmaceuticals assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQFUSN
Beta(0.69)
Shares Outstanding84.7M
Average Volume (10 days)350.9K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($1.41)
Sales (TTM)--
Book Value (MRQ)$2.86
Cash Flow (TTM)($0.99)
Cash (MRQ)$2.51

Analyst Views

Current Mean RecommendationHold
Strong Buy0
 
Buy0
 
Hold11
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Burak Eric
Chief Technology Officer
63,700
Acquire
Jan 4, 2024
Burak Eric
Chief Technology Officer
106,100
Acquire
Jan 4, 2024
Valliant John
Chief Executive Officer
192,200
Acquire
Jan 4, 2024
Valliant John
Chief Executive Officer
320,400
Acquire
Jan 4, 2024
Rawat Mohit
President and CBO
81,300
Acquire
Jan 4, 2024

Recent SEC Filings

DEFA14A
May 10, 2024
Company Events
May 10, 2024
Quarterly Financials
May 7, 2024
Company Events
May 7, 2024
Company Events
May 2, 2024
NEVER MISS AN UPDATE